Multiple Myeloma: Novel Agents Robert A. Kyle, M.D. Germany June ...
Multiple Myeloma: Novel Agents Robert A. Kyle, M.D. Germany June ...
Multiple Myeloma: Novel Agents Robert A. Kyle, M.D. Germany June ...
SHOW LESS
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Refractory <strong>Multiple</strong> <strong>Myeloma</strong><br />
Treatment<br />
Bortezomib (VELCADE TM ) (PS-341)<br />
n = 193<br />
Response (CR/PR) 35%<br />
Duration response<br />
12 mo<br />
Richardson et al: NEJM 2003, 348:26.
Change language